Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
SLAM DRILLS MORE COPPER MINERALIZATION AT GOODWIN (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Braxia Scientific Corp C.BRAX

Alternate Symbol(s):  BRAXF

Braxia Scientific Corp. is a Canada-based company, which is primarily focused on owning and operating multidisciplinary clinics, providing treatment for mental health disorders, and research activities related to discovering and commercializing drugs and delivery methods. The Company seeks to develop ketamine and derivatives and other psychedelic products from its Internet protocol (IP) development platform. The Company has clinic operations in the Canadian cities of Mississauga, Toronto, Kitchener-Waterloo, Ottawa and Montreal. The Company, through its wholly owned subsidiary, the Canadian Rapid Treatment Center of Excellence Inc., it operates multidisciplinary community-based clinics offering rapid-acting treatments for depression located in Mississauga, Toronto, Ottawa, Kitchener and Montreal. Its subsidiaries include Altmed Capital Corp., Artisan Growers Ltd., KetaMD, Inc., Novo Formulations Ltd. and Tassili Life Sciences Corp.


CSE:BRAX - Post by User

Braxia Scientific Corp
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(277)
•••
Post by sollmgon Dec 22, 2021 4:50pm
146 Views
Post# 34256147

Trading Totals - Canadian Exchanges

Trading Totals - Canadian Exchanges
House 2020 Totals Apr21 May21 Jun21 Jul21 Aug21 Sep21 Oct21 Nov21 1-17Dec21 20Dec21 21Dec21 22Dec21 Total House Dec Totals
National 1671897 1185054 2209750 1636115 994130 759666 1737054 580610 1025945 -48742 -35397 -112000 -97220 11506862 National -293359
TD 7540311 1500588 92495 1074527 573942 -67389 -53318 -260818 -4872 112146 55515 8480 3427 10575034 TD 179568
Scotia 5741513 -283233 521874 675778 313185 209660 -132504 94123 128298 -130569 -930 193030 0 7330225 Scotia 61531
Questrade 1413245 129235 -52554 97903 62465 100582 38668 2482 139575 23127 0 19500 -1429 1972799 Questrade 41198
RBC 8649473 848190 1014578 2376460 337550 309789 7620 224546 -1731650 117493 127000 -45925 10855 12245979 RBC 209423
ITG 1655289 -1693 112800 25550 44241 -19075 19022 126719 20721 31290 3704 -7000 -32500 1979068 ITG -4506
Instinet -212284 -58868 16700 210250 68000 271600 24000 78000 309000 61500 9000 13000 0 789898 Instinet 83500
Desjardins 250913 51559 -730 4279 90083 -3820 50478 -12352 19584 -3265 -3000 2000 108000 553729 Desjardins 103735
Merrill Lynch 176516 21330 28361 25739 -9516 109410 -146813 20750 54634 -101506 -74800 0 0 104105 Merrill Lynch -176306
PI 5986927 120000 -286500 -58500 3946 30100 -1500 -1300 5500 88000 0 0 0 5886673 PI 88000
Latimer -724339 -111827 -40939 -41247 -21414 -27740 -8697 -22406 -11091 -5118 642 -2885 367 -1016694 Latimer -6994
Credential 693812 140130 85110 19991 -10051 -104070 -71790 101280 -51284 -10791 5000 -4000 0 793337 Credential -9791
CIBC 2805354 106212 104850 175914 14195 -10193 122736 106556 667935 31328 73223 -28200 500 4170410 CIBC 76851
Canaccord 24749411 -511110 126356 320691 -109480 -12000 -35500 -31700 86600 -121788 -19000 -5000 -5000 24432480 Canaccord -150788
BMO 1714169 671987 514107 177891 -73324 194164 216489 -5037 276673 36546 -5000   -5000 3713665 BMO 26546
Anon -77485459 -3925738 -4412555 -6740261 -2395452 -1773549 -1738893 -923599 -919912 -25426 34013 -32000 1000 -100337831 Anon -22413
Raymond James 2488393 20900 238768 144518 0 0 22208 0 29244 0 0 -4000 0 2940031 Raymond James -4000
Manulife 90850 0 0 17000 0 0 -10500 0 -2400 0 0 0 0 94950 Manulife 0
Ind Alliance 269752 -26000 49500 5000 0 -10000 -30260 10000 0 0 -98000 0 17000 186992 Ind Alliance -81000
Laurentian 0 0 0 2000 0 0 0 0 0 0 0 0 0 2000 Laurentian 0
BBS 44704 4000 -200 -2300 -500 -300 8000 0 0 -1000 0 0 0 52404 BBS -1000
Virtu 0 0 -3277 -4098 0 0 0 0 0 0 0 0 0 -7375 Virtu 0
Haywood -121626 50046 1000 -8000 100000 0 0 0 0 0 0 0 0 21420 Haywood 0
Fidelity -266636 25200 0 -135200 0 0 -16500 -90000 -42000 0 0 0 0 -525136 Fidelity 0
Mackie 1340817 75000 0 0 0 -50000 0 0 0 0 0 0 0 1365817 Mackie 0
GMP -390000 20000 0 0 0 -10000 0 0 0 0 0 0 0 -380000 GMP 0
Interactive 0 -5766 0 0 0 0 0 0 -500 -175000 -72000 0 0 -253266 Interactive -247000
Pershing 326581 -14696 0 0 0 15165 0 2146 0 21775 0 0 0 350971 Pershing 21775
Leed 126300 -30500 0 0 18000 88000 0 0 0 0 0 0 0 201800 Leed 0
Eight 10865800 0 0 0 0 0 0 0 0 0 0 0 0 10865800 Eight 0
Clarus 429500 0 0 0 0 0 0 0 0 0 0 0 0 429500 Clarus 0
Echelon 85117 0 0 0 0 0 0 0 0 0 0 0 0 85117 Echelon 0
Credit Suisse 1700 0 0 0 0 0 0 0 0 0 0 0 0 1700 Credit Suisse 0
Morgan Stanley 10100 0 0 0 0 0 0 0 0 0 0 0 0 10100 Morgan Stanley 0
Beacon 15000 0 0 0 0 0 0 0 0 0 0 0 0 15000 Beacon 0
Velocity 140900 0 0 0 0 0 0 0 0 0 0 0 0 140900 Velocity 0
Cormark -65000 0 0 0 0 0 0 0 0 0 0 0 0 -65000 Cormark 0
Integral -1000 0 0 0 0 0 0 0 0 0 0 0 0 -1000 Integral 0
CSE Buy-in 27000 0 0 0 0 0 0 0 0 0 0 0 0 27000 CSE Buy-in 0

<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities